Palmer Knight Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.64M Buy
22,675
+2,243
+11% +$737K 3.24% 21
2025
Q4
$7.16M Buy
20,432
+10,162
+99% +$3.43M 3.76% 15
2025
Q3
$3.32M Sell
10,270
-253
-2% -$78.7K 1.57% 28
2025
Q2
$4.09M Sell
10,523
-20
-0.2% -$8.04K 1.74% 30
2025
Q1
$4.59M Sell
10,543
-174
-2% -$69.8K 2.23% 26
2024
Q4
$3.95M Buy
10,717
+213
+2% +$89.1K 1.77% 28
2024
Q3
$5.46M Buy
10,504
+49
+0.5% +$26.2K 2.4% 28
2024
Q2
$5.67M Buy
10,455
+88
+0.8% +$46.5K 2.71% 23
2024
Q1
$5.38M Buy
+10,367
New +$5.16M 2.62% 25

Other funds holding ELV

Palmer Knight Company's ELV Position: Q1 2026 in Review

Palmer Knight Company increased its Elevance Health (ELV) stake by 11% in Q1 2026, buying an estimated $737K and bringing the position to 22,675 shares worth $6.64M. The position accounts for 3.24% of the portfolio, ranked #21.

Palmer Knight Company first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.16M in Q4 2025. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Palmer Knight Company held 22,675 shares of Elevance Health worth $6.64M as of Q1 2026.
  • Palmer Knight Company bought 2,243 Elevance Health shares in Q1 2026, an estimated $737K.
  • Elevance Health made up 3.24% of Palmer Knight Company's portfolio in Q1 2026, its #21 holding.
  • Palmer Knight Company first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
  • Palmer Knight Company's Elevance Health position peaked at $7.16M in Q4 2025.
  • 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Palmer Knight Company's 13F filing for Q1 2026, filed 12 May 2026.